Inicio › Cáncer metastásico › Colorado › Denver
Ensayos clínicos de Cáncer metastásico en Denver, CO
29 estudios para Cáncer metastásico buscan participantes en centros de Denver y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
ReclutandoFase 1
- Sarah Cannon Research Institute at HealthOne, Denver
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
ReclutandoFase 1/2
- Rocky Mountain Cancer Center, Denver
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
ReclutandoFase 1
- SCRI at HealthOne, Denver
A Study of ASP3082 in Adults With Advanced Solid Tumors
ReclutandoFase 1
- Denver HealthONE Drug Development Unit, Denver
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
ReclutandoFase 3
- Intermountain Health Cancer Center Saint Joseph, Denver
- Intermountain Health Saint Joseph Hospital - Research Office, Denver
- Intermountain Health Saint Joseph Hospital, Denver
- y 3 más
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
ReclutandoFase 3
- Research Site, Denver
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
ReclutandoFase 2
- Saint Joseph Hospital - Cancer Centers of Colorado, Denver
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
ReclutandoFase 1/2
- University of Colorado Cancer Center, Denver
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
ReclutandoFase 3
- AdventHealth Medical Group - Porter, Denver
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
ReclutandoFase 3
- AdventHealth Medical Group - Porter, Denver
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
ReclutandoFase 1/2
- UCHealth Cherry Creek Medical Center, Denver
- Rocky Mountain Cancer Centers,LLP, Denver
Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
ReclutandoFase 1/2
- Sarah Cannon Research Institute at HealthONE, Denver
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- Clinical Study Site, Denver
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
ReclutandoFase 1
- Sarah Cannon Research Institute at HealthOne, Denver
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
ReclutandoFase 1/2
- Avenzo Therapeutics Recruiting Site, Denver
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
ReclutandoFase 1
- Sarah Cannon Research Institute Denver, Denver
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
ReclutandoFase 1
- Sarah Cannon Research Institute at HealthONE, Denver
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
ReclutandoFase 1/2
- Crinetics Study Site, Denver
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- Rocky Mountain Cancer Center, Denver
- Sarah Cannon Research Institute at HealthONE, Denver
A Study of PYX-201 in Advanced Solid Tumors
ReclutandoFase 1
- SCRI - HealthOne Denver, Denver
CT-95 in Advanced Cancers Associated With Mesothelin Expression
ReclutandoFase 1
- Context Investigational Site, Denver
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
ReclutandoFase 2/3
- The Melanoma & Skin Cancer Institute, Englewood · A 6 mi de distancia
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
ReclutandoFase 1
- Sarah Cannon Research Institute (SCRI) at HealthONE, Denver
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
ReclutandoFase 1
- Sarah Cannon Research Institute at HealthONE, Denver
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- Sarah Cannon Research Institute at HealthONE, Denver
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
ReclutandoFase 1
- Sarah Cannon Research Institute at HealthONE, Denver
Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma
ReclutandoFase 1/2
- Sarah Cannon Research Institute (SCRI) - Denver HealthONE Location, Denver
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Denver
ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)
ReclutandoFase 1
- SCRI Denver Drug Development Unit, Denver
Ensayos de Cáncer metastásico en otras ciudades
- Houston, TX104 estudios
- New York City, NY93 estudios
- Nashville, TN70 estudios
- Boston, MA63 estudios
- Los Angeles, CA57 estudios
- St. Louis, MO54 estudios
- Arlington, VA53 estudios
- Philadelphia, PA46 estudios
- Chicago, IL45 estudios
- San Antonio, TX44 estudios
- Washington, DC43 estudios
- Dallas, TX42 estudios
Otros estudios en Denver
- Cáncer de seno29 estudios
- Cáncer de pulmón de células no pequeñas27 estudios
- Mieloma múltiple27 estudios
- Cáncer del colon y del recto23 estudios
- Melanoma19 estudios
- Cáncer de próstata19 estudios
- Cáncer (todos los tipos)18 estudios
- Cáncer de ovario16 estudios
- Cáncer de pulmón16 estudios
- Cáncer de endometrio15 estudios
- Linfoma no Hodgkin14 estudios
- Cáncer de páncreas13 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.